Literature DB >> 15088830

Rapid response of cystoid macular edema related to Nd:YAG laser capsulotomy to 0.5% ketorolac.

Michael S Lee1, Jonathan H Lass.   

Abstract

A 68-year-old woman who had had cataract surgery several years previously presented with decreasing visual acuity and posterior capsular opacification. She underwent an Nd:YAG laser capsulotomy, but developed decreased visual acuity secondary to cystoid macular edema 2 months after the procedure. She was immediately administered 0.5% ketorolac drops. Several days after initiating treatment, she noted an improvement in her vision. Eight days later, her vision had improved from 20/400 to 20/60. Three weeks later, her vision returned to her baseline of 20/30 and a fluorescein angiogram showed resolution of the edema. This may indicate that cystoid macular edema related to Nd:YAG laser capsulotomy is caused by prostaglandin release, and that it may be responsive to topical nonsteroidal drops.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15088830

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  3 in total

1.  Which procedure has more effect on macular thickness: primary posterior continuous capsulorhexis (PPCC) combined with phacoemulsification or Nd:YAG laser capsulotomy?

Authors:  Necip Kara; Ahmet Taylan Yazici; Ercument Bozkurt; Yusuf Yildirim; Ahmet Demirok; Omer Faruk Yilmaz
Journal:  Int Ophthalmol       Date:  2011-08-14       Impact factor: 2.031

2.  Can Routine Patients Be Safely Discharged After Neodymium-Doped Yttrium Aluminium Garnet Laser Posterior Capsulotomy?

Authors:  James G Richardson-May; Chuiki J La; Madalina A Chihaia; Holly Clarke; Michelle Light; Mohammed Rashid
Journal:  Cureus       Date:  2022-02-01

3.  The Effect of ND:YAG Laser Posterior Capsulotomy Size on Refraction, Intraocular Pressure, and Macular Thickness.

Authors:  Eyyup Karahan; Ibrahim Tuncer; Mehmet Ozgur Zengin
Journal:  J Ophthalmol       Date:  2014-03-03       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.